Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology, Clinical Science Track

Diagnostic and prognostic values of 18F-FDG PET/CT in cervical nodal metastatic carcinoma of unknown primary site

Xiaoli Lan, Honghong Liu and Yongxue Zhang
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 1523;
Xiaoli Lan
1Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Honghong Liu
1Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yongxue Zhang
1Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

1523

Objectives Carcinoma of unknown primary (CUP) represents a heterogeneous group of metastatic malignancies for which primary tumor site could not be identified after routine diagnostic methods. Cervical lymph nodes are relatively superficial and easily to be found, therefore, a majority of CUP patients are cervical nodal metastases of CUP (CCUP). The aim of this study was to investigate the diagnostic and prognostic values of 18F-FDG PET/CT in patients referred with CCUP.

Methods A total of 137 consecutive patients (95 males, 42 females, age range 24-84 y [average 55.77±11.71 y] ) with histological proven CCUP who underwent 18F-FDG PET/CT imaging to find primary tumors from Jan 2010 to Jun 2015 were retrospectively analyzed. The golden standard was the final clinical pathological diagnosis or long-term follow-up (蠅6 months) results, and the average time of follow-up was 21.7 months. The diagnostic sensitivity, specificity, accuracy, PPV and NPV of PET/CT imaging in detecting primary tumors were calculated. Kaplan-Meier analysis was conducted for survival analysis and to identify the presence of any prognostic factors (including age, gender, presence or absence of distant metastasis, side of lymph node involvement, histopathologic tumor type and primary site found or not by PET/CT imaging).

Results Of 137 patients, a total of 96 patients found primary tumors, in which 52 patients were diagnosed with pathology, and 44 with long-term follow-up. Whole-body 18F-FDG PET/CT scan correctly detected the primary tumor in 87 CCUP patients. The diagnostic sensitivity, specificity, accuracy, PPV and NPV were 90.6% (87/96), 80.5% (33/41), 87.6% (120/137), 91.6% (87/95) and 78.6% (33/42) respectively. Head/neck and lung were the most commonly primary tumor sites. However, the false positive and negative cases were also mainly seen in these sites. Fifty-six patients died in this set of cases, and the median survival time was 14 months. Discoveries of distant metastasis and inferior region of cervical lymph nodes metastasis (according to AJCC cervical lymph nodes classification, IV, V B, VI and VII as the inferior region) were associated with worse survival (χ2=20.990 and 12.277, respectively, both P6.5 were of higher mortality risk than those with SUVmax&#8804;6.5 (χ2=7.120, P<0.01).

Conclusions Whole-body 18F-FDG PET/CT scan is a valuable tool in the identification of the primary tumor site in patients with CCUP. Without the need of identification of the primary tumors, 18F-FDG PET/CT scans are of value in the assessment of prognosis according to the distant metastasis and region of cervical lymph nodes metastasis. This work was supported by the National High-tech R & D Program of China (863 Program, No. 2008AA02Z426).

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 57, Issue supplement 2
May 1, 2016
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Diagnostic and prognostic values of 18F-FDG PET/CT in cervical nodal metastatic carcinoma of unknown primary site
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Diagnostic and prognostic values of 18F-FDG PET/CT in cervical nodal metastatic carcinoma of unknown primary site
Xiaoli Lan, Honghong Liu, Yongxue Zhang
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 1523;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Diagnostic and prognostic values of 18F-FDG PET/CT in cervical nodal metastatic carcinoma of unknown primary site
Xiaoli Lan, Honghong Liu, Yongxue Zhang
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 1523;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology, Clinical Science Track

  • Relationships between preoperative FMISO- and FDG-PET parameters and the prognosis in patients with oral squamous cell carcinoma
  • Radiographic and laboratory assessment of bone metastases in castration-resistant prostate cancer patients undergoing Radium-223 dichloride therapy
  • STANDARDIZATION OF TUMOR VOLUME DELINEATION BY PET-CT AND CT IN PATIENTS OF HEAD AND NECK CANCER-A PRELIMINARY ANALYSIS
Show more Oncology, Clinical Science Track

MTA I: Other Tumors Posters

  • 131I SPECT-CT imaging in management of differentiated thyroid carcinoma (DTC)
  • The diagnostic accuracy and value of 18F-FDOPA PET/CT in assessment of neuroendocrine tumours of gastroenteropancreatic and thoracic origin
  • Heterogeneity in Somatostatin-Receptor(SSTR-)PET/CT can Predict Response to Radiopeptide Therapy and Overall Survival in Patients with SSTR-expressing Tumors - a Multicenter Retrospective Trial
Show more MTA I: Other Tumors Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire